Synthesis and pharmacology of the putative novel muscarinic agonist (S)-4-F-MePyMcN [(S)-4-(pyrrolidino)-1-methyl-2-butynyl-N-(4-fluorophenyl) carbamate oxalate]

By Athmani S.   Bradley K.N.   Harvey A.L.   Kornisiuk E.   Jerusalinsky D.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 935-941

Elsevier

Access to resources Recommend Favorite

Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology

By Marchese A.   George S.R.   Kolakowski L.F.   Lynch K.R.   O'Dowd B.F.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 9, 1999-09 ,pp. : 370-375

Elsevier

Access to resources Recommend Favorite

CI-1017, a functionally M 1 -selective muscarinic agonist: design, synthesis, and preclinical pharmacology

By Tecle H.   Schwarz R.D.   Barrett S.D.   Callahan M.J.   Caprathe B.W.   Davis R.E.   Doyle P.   Emmerling M.   Lauffer D.J.   Mirzadegan T.   Moreland D.W.   Lipiniski W.   Nelson C.   Raby C.   Spencer C.   Spiegel K.   Thomas A.J.   Jaen J.C.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 141-148

Elsevier

Access to resources Recommend Favorite

Bioisosteric Replacement and Related Analogs in the Design, Synthesis and Evaluation of Ligands for Muscarinic Acetylcholine Receptors

By  

Medicinal Chemistry, Vol. 10, Iss. 4, 2014-04 ,pp. : 361-375

Bentham Science Publishers

Access to resources Recommend Favorite

Allosterism at Muscarinic Receptors: Ligands and Mechanisms

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 6, 2005-06 ,pp. : 523-543

Bentham Science Publishers

Access to resources Recommend Favorite